Most people shopping for body recomposition help make the same mistake: they treat this like a single-category problem. They either go full “weight loss telehealth” and ignore peptide and peptide-adjacent tools, or they go full “research peptide” and end up with no medical supervision at all. The sweet spot, if it exists anywhere, sits at the intersection of those two worlds.
Here is how nine options I’ve actually investigated stack up.
Quick Comparison Table
| Brand | Est. Monthly Cost | Medical Oversight | Third-Party Testing | Ships in | Best For |
| FormBlends | $29-$389/vial, no membership | Yes, licensed physician + 503A pharmacy | Yes, per-batch, per-product | 47 states | GLP-1 + peptides under one prescription roof |
| Mochi Health | ~$99-$199/mo (comp.) | Obesity-medicine specialists | Not disclosed | Most US | Clinical GLP-1 care on a budget |
| Hims & Hers | $249-$399/mo (branded) | Yes, telehealth MD | FDA-approved meds | Most US | Slick app, branded-only post-2026 |
| Ro Body | ~$74-$149/mo + med | Yes, prior-auth team | FDA-approved meds | Most US | Insurance navigation + polish |
| Henry Meds | ~$179-$249 mo. 1 | Light-touch telehealth | Not published | Most US | Speed, convenience, cash-pay |
| Pepthrive | Varies per compound | None | Batch-specific COAs | US domestic | Research peptides, community-vetted |
| Paramount Peptides | Varies per compound | None | Third-party, strong BPC-157 scores | US domestic | Purity-focused research buyers |
| Ascension Peptides | Varies per compound | None | Third-party COAs published | US domestic | Broad catalog, fast shipping |
| Honest Peptide | Varies per compound | None | Every batch, purity + contaminants | US domestic | Research buyers who want documented transparency |
The Picks, Walked Through
1. FormBlends
Body recomposition almost always involves more than one compound. That is the core problem with most of the options on this list: a GLP-1-only telehealth brand can’t touch peptides, and a research-peptide vendor can’t write you a prescription for anything.
FormBlends is the only place I’ve found that puts compounded GLP-1s, growth-hormone secretagogues, recovery peptides, nootropics, and metabolic compounds behind a single physician intake. One licensed doctor signs off. Everything ships from a 503A compounding pharmacy operating under FDA cGMP standards.
The pricing is posted flat, before you create an account. Semaglutide runs $299 per vial. Tirzepatide is $349. BPC-157 is $54. CJC-1295/ipamorelin is $69. MK-677, which is not a peptide but a ghrelin mimetic with early human data on lean mass and sleep-stage quality, is $79. That is not a membership price plus a separate medication charge stacked on top. It is the number.
Coverage extends to 47 states. Cold-chain shipping is included.
The range matters for recomposition specifically because real body recomp tends to involve managing calories and appetite (GLP-1 territory), pushing recovery and protein synthesis (BPC-157, TB-500, IGF-1 territory), and sometimes addressing hormonal or sleep quality issues (sermorelin, MK-677 territory). One roof, one prescription framework.
Compounded medications are not FDA-approved. That is true here and everywhere. Say it out loud before you order anything.
2. Mochi Health
Mochi is my top pick if your goal is purely supervised GLP-1 treatment and your budget is tight. Compounded semaglutide at roughly $99 per month is among the lowest structured-supervision prices I’ve seen. What sets them apart from convenience-first brands is the clinician profile: board-certified obesity-medicine specialists, not general practitioners pulling double duty. They take insurance for branded meds too, so your path to Wegovy or Zepbound is cleaner if prior authorization eventually works out.
3. Hims & Hers
Hims & Hers is the most recognized name in this space, full stop. In March 2026 they settled with Novo Nordisk and exited compounded semaglutide. New patients now get branded medications: Wegovy around $299 a month, Zepbound around $399, oral Wegovy around $249. With commercial insurance and the manufacturer savings card, those prices can fall to nearly zero. If you have good insurance and want the slickest onboarding experience on this list, this is your option. If you want flexibility beyond GLP-1s, it isn’t.
4. Ro Body
Ro’s prior-authorization team is a real differentiator. Getting insurance to cover branded GLP-1s is genuinely annoying, and Ro has built infrastructure around that friction. Membership runs as low as $74 a month on an annual plan, with medication billed on top. Polished product, established track record, no frills missing that most people actually need.
5. Henry Meds
Speed is the selling point. Many Henry Meds patients report delivery within 24 to 72 hours of approval. Cash-pay, compounded GLP-1 programs start around $179 for month one. The tradeoff is lighter ongoing clinical monitoring compared to more specialist-heavy platforms. Fine for self-directed patients who already understand what they’re doing.
6. Pepthrive
Among research-peptide vendors, Pepthrive has earned consistent community trust over time. Batch-specific certificates of analysis, responsive customer support, and solid catalog coverage of the most common recovery and body-recomposition compounds: BPC-157, TB-500, CJC-1295, ipamorelin. No physician. No prescription. That line matters enormously. These are sold for research use, not human consumption, and that is not a technicality.
7. Paramount Peptides
Their BPC-157 turned up around 9.6 out of 10 in independent community purity testing roundups. That kind of specific third-party score is rare and worth noting. If BPC-157 is your primary interest and purity is your main concern, Paramount is the name I’d start with.
8. Ascension Peptides
US-based, fast domestic shipping, third-party COAs published, broad catalog. Ascension is a reliable workhorse option for research-peptide buyers. Nothing flashy, which is probably a point in their favor.
9. Honest Peptide
The name is a bit on the nose, but the practice backs it up: every batch is third-party tested for purity, weight accuracy, and contaminants, and the documentation is available. For buyers who want layered documentation rather than a single purity number, this is where I’d look.
A Few Things Worth Saying Plainly
The 2026 FDA warning letters sent to dozens of compounding and telehealth companies, combined with the Novo Nordisk settlement, reshuffled this space fast. Several brands that were compounding semaglutide six months ago no longer are. That is worth knowing before you sign up for anything based on a review written in 2024.
For peptides beyond GLP-1s, almost all the human evidence is early-stage or preclinical. Animal studies are interesting. They are not clinical trials. Anyone telling you otherwise is selling something harder than a peptide.
Talk to whoever manages your actual healthcare before starting any of this. That is not a disclaimer. It is just accurate.
Sources
- FDA.gov (compounding regulations, 503A pharmacy oversight, GLP-1 warning letters 2026)
- Examine.com (MK-677, BPC-157, semaglutide research summaries)
- Drugs.com (branded GLP-1 pricing and approval status)
- GoodRx.com (Wegovy, Zepbound, Ozempic cash and insurance pricing)
- Cleveland Clinic (body recomposition, obesity medicine)
- Verywell Health (telehealth weight loss platform comparisons)
- Healthline (compounded semaglutide explainers, GLP-1 drug class)
[internal: placement #1 | structure: Comparison-led, big table, scoring]
